Quote used 3rd time... "Pretty sure you’re hooked just

New Post Public Reply Private Reply Replies (2) Message Board
Goosebumps CDiddy #84266
597
Quote used 3rd time...

"Pretty sure you’re hooked just as hard as I am!"



I am not only hooked but landed and flopping on the bottom of the boat gasping for air and waiting for an conditionally EUA to save me some time and give me that last breath of air I need to settle my life into a retirement mode before fish heaven calls.

Yeah... you can say I am all in and the sides of the boats are to high for me to flip or flop out now. When you believe in the science... you just gotta trust your instincts as I have just kept swimming my way along prior to that hard hook set 19 months ago.

An afternoon PR right after closing would be the fresh breath of air we all need. Friday after hours announcements can be pretty exciting. It’s not that we have never had a Friday PR to dissect that PR all weekend long. No prior talk about a PR on this Friday would make it quite the surprise for us all.

Wishing and loving for that surprise to happen. Hope is always in my wheelhouse being a fisherman. If it doesn’t happen... then we will celebrate another day. I believe it is going to happen... it’s just a matter of when and sooner the better for us all. It’s not like next week isn’t soon enough for me.

We got this... it’s just a matter of time I keep telling myself and my friends and family. I am tired of tell them that anytime it could happen. But the truth is... it could.





Read More: https://investorshangout.com/post/newpost/605...z6qEuaflfe

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

BIC's Latest Voting Rights and Shares Disclosure Details

Updated Category News Views 180

Key Disclosure on Voting Rights and Shares As a reputable leader in stationery and consumer products, BIC is committed to transparency. Recently, they provided crucial insights into their corporate structure, particularly regarding the total number of voting rights and shares. This disclosure highlights the ongoing dedication towards maintaining clear communication with...

Continue Reading
AGCO Showcase: Innovations and Autonomy for 2026 Farmers

Updated Category News Views 212

AGCO (NYSE: AGCO) is strutting its stuff at the 2026 Commodity Classic in San Antonio from February 25-27. Picture this: over 24,000 square feet jam-packed with cutting-edge agricultural machinery aimed at farmers who want to boost their operations. Yeah, the buzz is all about showcasing their big guns like Fendt®, Massey Ferguson®, and PTx™—but dig deeper into...

Continue Reading
Revolutionizing Healthcare Marketing with Ignite Pulse Solutions

Updated Category News Views 371

Revolutionizing Healthcare Marketing with Ignite Pulse Solutions In the shifting landscape of healthcare marketing, WebMD Ignite introduces a significant enhancement aimed at assisting health systems in thriving amidst the challenges posed by AI and budget constraints. Presenting Ignite Pulse™, this groundbreaking solution offers a comprehensive growth strategy designed...

Continue Reading
Eupraxia Pharmaceuticals Welcomes New Leaders to Innovate Growth

Updated Category News Views 190

Eupraxia Pharmaceuticals Expands Leadership Team Eupraxia Pharmaceuticals Inc. (TSX: EPRX) (NASDAQ: EPRX), known for its innovative approaches in drug delivery technology, has recently announced two significant additions to its leadership. Dr. Amanda Malone has been appointed as the Chief Operating and Scientific Officer, alongside Dr. Rahul Sarugaser as Executive Vice...

Continue Reading
Illumina Enhances Oncology Solutions for Better Cancer Care

Updated Category News Views 186

Illumina's Latest Developments in Oncology In an exciting development, Illumina Inc. (NASDAQ: ILMN) has announced a significant expansion in its clinical oncology portfolio. This move aims to set a new standard of care and enhance access to precision therapies through advanced genomic profiling. Following the recent FDA approval of Illumina's TSO Comprehensive test, the...

Continue Reading